In animals, BPC 157 has an anti-inflammatory effect and therapeutic effects in functional recovery and the rescue of somatosensory neurons in the sciatic nerve after transection, upon brain injury after concussive trauma, and in severe encephalopathies
Changes in sleep, stress, caffeine consumption, and blood glucose may also play a role
RETRACTED ARTICLE: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis, Springer Science and Business Media LLC, (2019)
On March 2, 2023 and June 16, 2023 Lexaria announced that in pre-clinical diabetes study DIAB-A22-1 in obese diabetic-conditioned animals, DehydraTECH-CBD achieved each of the following: Lowered blood glucose levels by 19.9% (p0.05) Lowered overall body weight by 7% sustained over 8 weeks Increased locomotor activity (p0.05) Lowered triglyceride levels by more than 25% (p0.007) Lowered blood urea nitrogen levels by 27.9% (p0.001) On August 2, 2023 Lexaria announced its intention to study weight loss and diabetes control in a human population using DehydraTECH-CBD
Time zero
It appears that severe disease from the virus is random among children